secwatch.observer — SEC 8-K summary
======================================

Issuer:     RHYTHM PHARMACEUTICALS, INC. (RYTM)
CIK:        0001649904
Form:       8-K
Filed at:   2023-08-21T23:59:59+00:00
Accession:  0001104659-23-093945
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Rhythm Pharmaceuticals raises $50M via ATM equity offering of 2M shares
-----------------------------------------------------------------------

- Sold ~2.019M shares of common stock from Aug 10-21, 2023, for gross proceeds of ~$50M.
- Proceeds, plus existing cash and anticipated $24.4M milestone from Healthcare Royalty Partners, fund operations into 2026.
- Funds to support global commercialization of IMCIVREE (setmelanotide) and rare MC4R pathway clinical programs.
- ATM program originally authorized up to $100M; this drawdown represents half the capacity.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649904/000110465923093945/0001104659-23-093945-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649904/000110465923093945/tm2324286d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-093945

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer